cultivate (MD) Capital Funds Portfolio Company Virtual Incision Announces Completion of Clinical Study Enrollment for its MIRA® Platform
FDA decision supported by an interim clinical study report on patient safety Grand Rapids, Mich., February 28, 2023— cultivate(MD) Capital Funds LP, funds that are focused on investments into early-stage healthcare companies with innovative technologies, announced today that one of their portfolio companies, Lincoln, Nebraska-based Virtual Incision Corporation, has completed its U.S. Food and Drug […]